Alerje Secures $3.1M to Transform Life for Over 220 Million Affected by Food Allergies

Alerje is thrilled to announce that we have successfully raised $3,100,000 in our latest funding round—a significant milestone that will propel our mission to transform the world of food allergy management.

At Alerje, we firmly believe that food allergies should not get in the way of making every moment in our lives count.

With more than 220 million people worldwide impacted by food allergies, our proactive patient design approach is dedicated to improving daily quality of life by empowering individuals through innovative and tailored solutions.

This fresh influx of capital will be strategically invested in advancing our research and development initiatives, allowing us to refine and expand our cutting-edge technologies.

Our goal is to create safer, more reliable systems for allergen detection and management, ensuring that patients feel supported in every aspect of their journey.

Additionally, these funds will fuel our efforts to enhance educational outreach and patient support programs, providing critical resources and expertise to families navigating food allergies.

As we build on our initial success, we are also excited to explore new partnerships that align with our vision of a future where food allergies no longer restrict the full spectrum of life’s experiences.

This achievement is not only a financial victory but also a strong vote of confidence in our mission from our dedicated investors and supporters.

Every dollar raised moves us closer to a world where managing food allergies is more predictable, effective, and less burdensome—so that everyone can truly make every moment count.

We are deeply grateful for this support and look forward to the promising advances the near future holds.